Literature DB >> 19362643

Genetic analysis of nystatin and amphotericin biosynthesis.

Sergey Zotchev1, Patrick Caffrey.   

Abstract

The polyene macrolides nystatin A1 and amphotericin B are effective but toxic antifungal antibiotics that are also active against enveloped viruses, protozoan parasites and pathogenic prion proteins. This chapter describes methods for genetic manipulation of the amphotericin and nystatin producers, Streptomyces nodosus and Streptomyces noursei. These techniques have been used to engineer the biosynthesis of several analogues of both polyenes. Methods for production, identification, purification and characterization of new analogues are also discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19362643     DOI: 10.1016/S0076-6879(09)04611-4

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  4 in total

1.  Construction of a new integrating vector from actinophage ϕOZJ and its use in multiplex Streptomyces transformation.

Authors:  Bryan Ko; John D'Alessandro; Lee Douangkeomany; Spencer Stumpf; Ashby deButts; Joshua Blodgett
Journal:  J Ind Microbiol Biotechnol       Date:  2019-11-08       Impact factor: 3.346

2.  Unusual and Highly Bioactive Sesterterpenes Synthesized by Pleurotus ostreatus during Coculture with Trametes robiniophila Murr.

Authors:  Xiao-Ting Shen; Xu-Hua Mo; Li-Ping Zhu; Ling-Ling Tan; Feng-Yu Du; Qian-Wen Wang; Yuan-Ming Zhou; Xiao-Jie Yuan; Bin Qiao; Song Yang
Journal:  Appl Environ Microbiol       Date:  2019-07-01       Impact factor: 4.792

Review 3.  Biosynthesis and pathway engineering of antifungal polyene macrolides in actinomycetes.

Authors:  Dekun Kong; Mi-Jin Lee; Shuangjun Lin; Eung-Soo Kim
Journal:  J Ind Microbiol Biotechnol       Date:  2013-03-21       Impact factor: 3.346

4.  An Amphotericin B Derivative Equally Potent to Amphotericin B and with Increased Safety.

Authors:  Armando Antillón; Alexander H de Vries; Marcel Espinosa-Caballero; José Marcos Falcón-González; David Flores Romero; Javier González-Damián; Fabiola Eloísa Jiménez-Montejo; Angel León-Buitimea; Manuel López-Ortiz; Ricardo Magaña; Siewert J Marrink; Rosmarbel Morales-Nava; Xavier Periole; Jorge Reyes-Esparza; Josué Rodríguez Lozada; Tania Minerva Santiago-Angelino; María Cristina Vargas González; Ignacio Regla; Mauricio Carrillo-Tripp; Mario Fernández-Zertuche; Lourdes Rodríguez-Fragoso; Iván Ortega-Blake
Journal:  PLoS One       Date:  2016-09-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.